Tech Company Financing Transactions
StroMedix Funding Round
On 1/25/2011, StroMedix raised $2 million in investment from private investors.
Transaction Overview
Company Name
Announced On
1/25/2011
Transaction Type
Debt
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
One Canal Park 1120
Cambridge, MA 02141
USA
Cambridge, MA 02141
USA
Phone
Website
Email Address
Overview
Stromedix is a clinical-stage biotechnology company committed to developing novel drugs to treat fibrotic organ failure. Stromedix will focus initially on chronic indications but plans to leverage its expertise and expand its therapeutic pipeline into related settings such as acute organ failure and cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Dan Lynch
Chief Executive Officer
Michael Gilman
Chief Medical Officer
Brad Maroni
VP - R & D
Shelia Violette
Browse more venture capital transactions:
Prev: 1/25/2011: Digital Assent venture capital transaction
Next: 1/25/2011: Solar Universe venture capital transaction
Share this article
News on VC Transactions
We record tech company VC transactions. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs